Testing strategies used in the diagnosis of rare inherited bleeding disorders

References

• Castaman G, Eikenboom JC, Bertina RM, et al. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost. 1999 Sep;82(3):1065–1070.
   PubMed Web of Science ®Google Scholar
• Nugent D, Acharya SS, Baumann KJ, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders. Expert Rev Hematol. 2023 Mar;16(sup1):55–70. doi:10.1080/17474086.2023.2175661.
   PubMedGoogle Scholar
• Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019 Oct 15;171(8):540–546. doi:10.7326/M19-1208
   PubMed Web of Science ®Google Scholar
• Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The hemophilia surveillance system project investigators. Am J Hematol. 1998 Dec;59(4):288–294.
   PubMed Web of Science ®Google Scholar
• Richter T, Nestler-Parr S, Babela R, et al. Rare disease terminology and definitions-a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015 Sep;18(6):906–914.
   PubMed Web of Science ®Google Scholar
• Rare coagulation disorder resource room: national hemophilia foundation; [Oct 2022]. Available from: https://www.hemophilia.org/healthcare-professionals/education-resources/rare-coagulation-resource-room
   Google Scholar
• Peyvandi F, Palla R, Menegatti M, et al. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost. 2009 Jun;35(4):349–355.
   PubMed Web of Science ®Google Scholar
• Biss TT, Blanchette VS, Clark DS, et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010 May;8(5):950–956.
   PubMed Web of Science ®Google Scholar
• Adler M, Kaufmann J, Alberio L, et al. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J Thromb Haemost. 2019 Jul;17(7):1104–1112.
   PubMed Web of Science ®Google Scholar
• Bowman ML, James PD. Bleeding scores for the diagnosis of von Willebrand disease. Semin Thromb Hemost. 2017 Jul;43(5):530–539.
   PubMed Web of Science ®Google Scholar
• Mittal N, Naridze R, James P, et al. Utility of a paediatric bleeding questionnaire as a screening tool for von Willebrand disease in apparently healthy children. Haemophilia. 2015 Nov;21(6):806–811.
   PubMed Web of Science ®Google Scholar
• Juul-Kristensen B, Schmedling K, Rombaut L, et al. Measurement properties of clinical assessment methods for classifying generalized joint hypermobility-A systematic review. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):116–147.
   PubMed Web of Science ®Google Scholar
• Malfait F, Castori M, Francomano CA, et al. The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020 Jul 30;6(1):64. doi:10.1038/s41572-020-0194-9.
   PubMed Web of Science ®Google Scholar
• Demmler JC, Atkinson MD, Reinhold EJ, et al. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison. BMJ Open. 2019 Nov 4;9(11):e031365. doi:10.1136/bmjopen-2019-031365
   PubMed Web of Science ®Google Scholar
• Artoni A, Bassotti A, Abbattista M, et al. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome. J Thromb Haemost. 2018 Dec;16(12):2425–2431.
   PubMed Web of Science ®Google Scholar
• Baker RI, O’Donnell JS. How I treat bleeding disorder of unknown cause. Blood. 2021 Nov 11;138(19):1795–1804.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Seminars in thrombosis and hemostasis. 2008 Oct;34(7):612–634. doi: 10.1055/s-0028-1104540.
   Google Scholar
• Adcock DM, Hoefner DM, Kottke-Marchant K, et al. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline-Fifth edition. CLSI Doc. 2008;28(5):H21–A5.
   Google Scholar
• Platelet Glycoprotein Expression 2022 [ updated December 2022; cited Dec 2022]. Available from: https://www.versiti.org/diagnostic-labs-test-menu/catalog/platelet-glycoprotein-expression-pge
   Google Scholar
• Platelet surface glycoprotein by flow cytometry. [cited 2022 Dec 2022]. Available from: https://www.mayocliniclabs.com/test-catalog/overview/64278
   Google Scholar
• Lawrie AS, Kitchen S, Efthymiou M, et al. Determination of APTT factor sensitivity–the misguiding guideline. Int J Lab Hematol. 2013 Dec;35(6):652–657.
   PubMed Web of Science ®Google Scholar
• Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007 Jul;82(7):864–873. doi:10.4065/82.7.864.
   PubMed Web of Science ®Google Scholar
• Massignon D, Moulsma M, Bondon P, et al. Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastins. Thromb Haemost. 1996 Apr;75(4):590–594. doi:10.1055/s-0038-1650327.
   PubMed Web of Science ®Google Scholar
• CLSI, One Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) test. Approved Guideline-Second Edition. Second Edition. ( CLSI document H47-A2). Clinical and Laboratory Standards Institute: Wayne PA; 2008.
   Google Scholar
• Toulon P, Eloit Y, Smahi M, et al. In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies. Int J Lab Hematol. 2016 Aug;38(4):389–396. doi:10.1111/ijlh.12499.
   PubMed Web of Science ®Google Scholar
• Mischke R, Junker J, Deegen E. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma. Vet j. 2006 Jan;171(1):114–119.
   PubMed Web of Science ®Google Scholar
• CLSI. Determination of coagulation factor activities using the one-stage clotting assay. CLSI Guideline. 2016;H48. 2nd Edition
   Google Scholar
• Peyvandi F, Oldenburg J, Friedman KD. A critical appraisal of one-stage and chromogenic assays of factor VIII activity. J Thromb Haemost. 2016 Feb;14(2):248–261.
   PubMed Web of Science ®Google Scholar
• Sakai T. Comparison between thromboelastography and thromboelastometry. Minerva Anestesiol. 2019 Dec;85(12):1346–1356.
   PubMed Web of Science ®Google Scholar
• Wikkelso A, Wetterslev J, Moller AM, et al. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):p. CD007871. doi: 10.1002/14651858.CD007871.pub3
   Google Scholar
• Nogami K. The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 2016 Aug;174(4):503–514. doi:10.1111/bjh.14148.
   PubMed Web of Science ®Google Scholar
• Schmidt AE, Israel AK, Refaai MA. The utility of thromboelastography to guide blood product transfusion. Am J Clin Pathol. 2019 Sep 9;152(4):407–422.
   PubMed Web of Science ®Google Scholar
• Ninivaggi M, de Laat-Kremers R, Tripodi A, et al. Recommendations for the measurement of thrombin generation: communication from the ISTH SSC subcommittee on lupus anticoagulant/antiphospholipid antibodies. J Thromb Haemost. 2021 May;19(5):1372–1378.
   PubMed Web of Science ®Google Scholar
• Depasse F, Binder NB, Mueller J, et al. Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine. J Thromb Haemost. 2021 Dec;19(12):2907–2917.
   PubMed Web of Science ®Google Scholar
• Kintigh J, Monagle P, Ignjatovic V. A review of commercially available thrombin generation assays. Res Pract Thromb Haemost. 2018 Jan;2(1):42–48.
   PubMed Web of Science ®Google Scholar
• Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010 Dec;134(6):955–963.
   PubMed Web of Science ®Google Scholar
• Harrison P, Mackie I, Mumford A, et al. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011 Oct;155(1):30–44.
   PubMed Web of Science ®Google Scholar
• Hvas AM, Favaloro EJ. Platelet function testing in pediatric patients. Expert Rev Hematol. 2017 Apr;10(4):281–288.
   PubMed Web of Science ®Google Scholar
• Nava T, Rivard GE, Bonnefoy A. Challenges on the diagnostic approach of inherited platelet function disorders: is a paradigm change necessary? Platelets. 2018 Mar;29(2):148–155.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Semin Thromb Hemost. 2006 Jul;32(5):537–545.
   PubMed Web of Science ®Google Scholar
• Buyukasik Y, Karakus S, Goker H, et al. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagul Fibrinolysis. 2002 Jun;13(4):349–353. doi:10.1097/00001721-200206000-00011.
   PubMed Web of Science ®Google Scholar
• Karger R, Donner-Banzhoff N, Muller HH, et al. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis. Platelets. 2007 Jun;18(4):249–260.
   PubMed Web of Science ®Google Scholar
• Hayward CP, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost. 2006 Feb;4(2):312–319.
   PubMed Web of Science ®Google Scholar
• Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost. 2009 Mar;35(2):150–157.
   PubMed Web of Science ®Google Scholar
• CLSI. Platelet function testing by aggregometry; approved guideline. Clin Lab Standards Inst. 2008;28(31):1–45.
   Google Scholar
• Hayward CPM. How I investigate for bleeding disorders. Int J Lab Hematol. 2018 May;40(Suppl 1):6–14.
   PubMedGoogle Scholar
• Gresele P, Harrison P, Gachet C. Subcommittee on platelet physiology of the international society on T, Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015 Feb;13(2):314–322.
   PubMed Web of Science ®Google Scholar
• Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol. 1984 Aug;37(8):874–878.
   PubMed Web of Science ®Google Scholar
• Badin MS, Graf L, Iyer JK, et al. Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder. Int J Lab Hematol. 2016 Dec;38(6):648–657.
   PubMed Web of Science ®Google Scholar
• Chen D, Uhl CB, Bryant SC, et al. Diagnostic laboratory standardization and validation of platelet transmission electron microscopy. Platelets. 2018 Sep;29(6):574–582.
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Harmsze AM, Elsenberg EH, et al. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets. 2008 Nov;19(7):479–488.
   PubMed Web of Science ®Google Scholar
• Moenen F, Vries MJA, Nelemans PJ, et al. Screening for platelet function disorders with Multiplate and platelet function analyzer. Platelets. 2019;30(1):81–87. DOI:10.1080/09537104.2017.1371290
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405–424.
   PubMed Web of Science ®Google Scholar
• Gouw SC, van den Berg HM, Oldenburg J, et al. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis [Meta-Analysis [Review]. Blood. 2012 Mar 22;119(12):2922–2934. doi:10.1182/blood-2011-09-379453
   PubMed Web of Science ®Google Scholar
• Reijnen MJ, Peerlinck K, Maasdam D, et al. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. Blood. 1993 Jul 1;82(1):151–158. doi:10.1182/blood.V82.1.151.bloodjournal821151
   PubMed Web of Science ®Google Scholar
• Watson SP, Lowe GC, Lordkipanidze M, et al. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost. 2013 Jun;11 Suppl 1:351–363.
   PubMed Web of Science ®Google Scholar
• Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):385–399. doi:10.1182/asheducation-2017.1.385.
   PubMedGoogle Scholar
• Freson K, Wijgaerts A, van Geet C. Update on the causes of platelet disorders and functional consequences. Int J Lab Hematol. 2014 Jun;36(3):313–325.
   PubMed Web of Science ®Google Scholar
• Toulon P, Berruyer M, Brionne-Francois M, et al. Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining the age-specific reference ranges. Thromb Haemost. 2016 Jul 4;116(1):9–16. doi:10.1160/TH15-12-0964.
   PubMed Web of Science ®Google Scholar
• Dorgalaleh A, Tabibian S, Hosseini S, et al. Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagul Fibrinolysis. 2016 Jun;27(4):361–364.
   PubMed Web of Science ®Google Scholar
• Naderi M, Dorgalaleh A, Alizadeh S, et al. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol. 2014 Nov;100(5):443–449.
   PubMed Web of Science ®Google Scholar
• Megy K, Downes K, Morel-Kopp MC, et al. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: communication from the ISTH SSC subcommittee on genomics in thrombosis and hemostasis. J Thromb Haemost. 2021 Oct;19(10):2612–2617.
   PubMed Web of Science ®Google Scholar
• Ver Donck F, Downes K, Freson K. Strengths and limitations of high-throughput sequencing for the diagnosis of inherited bleeding and platelet disorders. J Thromb Haemost. 2020 Aug;18(8):1839–1845. doi:10.1111/jth.14945.
   PubMed Web of Science ®Google Scholar
• Sivapalaratnam S, Collins J, Gomez K. Diagnosis of inherited bleeding disorders in the genomic era. Br J Haematol. 2017 Nov;179(3):363–376.
   PubMed Web of Science ®Google Scholar
• Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014 Nov;167(3):304–326.
   PubMed Web of Science ®Google Scholar
• Franchini M, Marano G, Pupella S, et al. Rare congenital bleeding disorders. Ann Transl Med. 2018 Sep;6(17):331.
   PubMed Web of Science ®Google Scholar
• Peyvandi F, Menegatti M, Palla R. Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management. Semin Thromb Hemost. 2013 Sep;39(6):579–584.
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004 Sep 1;104(5):1243–1252.
   PubMed Web of Science ®Google Scholar
• Girolami A, Berti de Marinis G, Bonamigo E, et al. Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua). Eur J Haematol. 2011 Feb;86(2):135–139.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Kojima T, Emi N, et al. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304–>trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem. 1994 Mar 11;269(10):7355–7363. doi:10.1016/S0021-9258(17)37292-7
   PubMed Web of Science ®Google Scholar
• Sabater-Lleal M, Chillon M, Howard TE, et al. Functional analysis of the genetic variability in the F7 gene promoter. Atherosclerosis. 2007 Dec;195(2):262–268.
   PubMed Web of Science ®Google Scholar
• Poulsen AL, Pedersen LH, Hvas AM, et al. Assay discrepancy in mild haemophilia A: entire population study in a National haemophilia centre. Haemophilia. 2009 Jan;15(1):285–289.
   PubMed Web of Science ®Google Scholar
• Trossaert M, Boisseau P, Quemener A, et al. Prevalence, biological phenotype and genotype in moderate/mild hemophilia a with discrepancy between one-stage and chromogenic factor VIII activity. J Thromb Haemost. 2011 Mar;9(3):524–530.
   PubMed Web of Science ®Google Scholar
• Trossaert M, Lienhart A, Nougier C, et al. Diagnosis and management challenges in patients with mild haemophilia a and discrepant FVIII measurements. Haemophilia. 2014 Jul;20(4):550–558.
   PubMed Web of Science ®Google Scholar
• Kihlberg K, Strandberg K, Rosen S, et al. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B. Haemophilia. 2017 Jul;23(4):620–627.
   PubMed Web of Science ®Google Scholar
• Lak M, Keihani M, Elahi F, et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol. 1999 Oct;107(1):204–206.
   PubMed Web of Science ®Google Scholar
• Dorgalaleh A, Tabibian S, Shams M, et al. Laboratory diagnosis of factor XIII deficiency in developing countries: an Iranian experience. Lab Med. 2016 Aug;47(3):220–226.
   PubMed Web of Science ®Google Scholar
• Kohler HP, Ichinose A, Seitz R, et al. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011 Jul;9(7):1404–1406.
   PubMed Web of Science ®Google Scholar
• Karimi M, Peyvandi F, Naderi M, et al. Factor XIII deficiency diagnosis: challenges and tools. Int J Lab Hematol. 2018 Feb;40(1):3–11.
   PubMed Web of Science ®Google Scholar
• Ilich A, Bokarev I, Key NS. Global assays of fibrinolysis. Int J Lab Hematol. 2017 Oct;39(5):441–447.
   PubMed Web of Science ®Google Scholar
• Booth N, Bachman F. Plasminogen-Plasmin System. In: Colman R, Marder V, Clowes A, George J Goldhaber S, editors. Hemostasis and thrombosis: basic principles and clinical practice. 5th Edition ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006. p. 335–364.
   Google Scholar
• Gram J, Declerck PJ, Sidelmann J, et al. Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb Haemost. 1993 Nov 15;70(5):852–857. doi:10.1055/s-0038-1649682
   PubMed Web of Science ®Google Scholar
• Hayward CP, Moffat KA. Laboratory testing for bleeding disorders: strategic uses of high and low-yield tests. Int J Lab Hematol. 2013 Jun;35(3):322–333.
   PubMed Web of Science ®Google Scholar
• Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010 Oct;28(5):e72–91.
   PubMed Web of Science ®Google Scholar
• Balduini CL, Savoia A. Genetics of familial forms of thrombocytopenia. Hum Genet. 2012 Dec;131(12):1821–1832.
   PubMed Web of Science ®Google Scholar
• Israels SJ, Kahr WH, Blanchette VS, et al. Platelet disorders in children: a diagnostic approach. Pediatr Blood Cancer. 2011 Jun;56(6):975–983.
   PubMed Web of Science ®Google Scholar
• Quiroga T, Goycoolea M, Munoz B, et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost. 2004 Jun;2(6):892–898.
   PubMed Web of Science ®Google Scholar
• Hayward CP, Pai M, Liu Y, et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost. 2009 Apr;7(4):676–684.
   PubMed Web of Science ®Google Scholar
• Quiroga T, Goycoolea M, Matus V, et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol. 2009 Dec;147(5):729–736.
   PubMed Web of Science ®Google Scholar
• Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007 Mar;92(3):357–365.
   PubMed Web of Science ®Google Scholar
• Zaninetti C, Wolff M, Greinacher A. Diagnosing inherited platelet disorders: modalities and consequences. Hamostaseologie. 2021 Dec;41(6):475–488.
   PubMedGoogle Scholar
• Chaigneau M, James PD. Approach to the Patient with Bleeding. Hematol Oncol Clin North Am. 2021 Dec;35(6):1039–1049.
   PubMed Web of Science ®Google Scholar
• Heubel-Moenen F, Ansems LEM, Verhezen PWM, et al. Effectiveness and costs of a stepwise versus an all-in-one approach to diagnose mild bleeding disorders. Br J Haematol. 2022 Nov 28;200(6):792–801. doi:10.1111/bjh.18570
   PubMed Web of Science ®Google Scholar
• Asakai R, Chung DW, Davie EW, et al. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med. 1991 Jul 18;325(3):153–158. doi:10.1056/NEJM199107183250303
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, et al. Inheritance and bleeding in factor XI deficiency. Br J Haematol. 1988 Aug;69(4):521–528.
   PubMed Web of Science ®Google Scholar
• Chang SH, Tillema V, Scherr D. A “percent correction” formula for evaluation of mixing studies. Am J Clin Pathol. 2002 Jan;117(1):62–73.
   PubMed Web of Science ®Google Scholar
• Kershaw G, Orellana D. Mixing tests: diagnostic aids in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost. 2013 Apr;39(3):283–290.
   PubMed Web of Science ®Google Scholar
• Perez Botero J, Warad DM, He R, et al. Comprehensive platelet phenotypic laboratory testing and bleeding history scoring for diagnosis of suspected hereditary platelet disorders: a single-institution experience. Am J Clin Pathol. 2017 Jul 1;148(1):23–32. doi:10.1093/ajcp/aqx038
   PubMed Web of Science ®Google Scholar
• Gresele P, Orsini S, Noris P, et al. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the platelet physiology SSC. J Thromb Haemost. 2020 Mar;18(3):732–739.
   PubMed Web of Science ®Google Scholar